In IBD patients, an aberrant upregulation of Fas ligand (CD95L), BAX, and p53 has been observed in IECs—molecules typically restricted to immune and Paneth cells in healthy individuals [64]. This evidence concerns the gene FASLG and irritable bowel syndrome.